PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective is a research paper published in Acta Materia Medica (2022). On theSindex it has a DataRank of 0. It has been cited 65 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA177910
NCI NIH HHS
Grant: R35 CA253027
National Institutes of Health
Grant: 5R01CA177910-07
Novel regulation of PI3K/Akt to direct targeted breast cancer therapies
FWCI
4.95
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals